CatSci Ltd, an award-winning innovation partner for medicines development, are pleased to share that we will be attending DCAT Week, New York City, on 20th – 23rd March 2023.
Hosted by the Drug, Chemical & Associated Technologies Association, DCAT Week is a global annual event for the bio/pharmaceutical manufacturing chain.
Attending DCAT will be:
- Dr Simon Tyler, Chief Commercial Officer
- Dr Joe Renny MBA, Head of Corporate Development
Simon and Joe are looking forward to discussing your CMC challenges and how our in-depth drug development expertise and end-in-mind approach can accelerate the delivery of your best-in-class medicines.
For your early development projects, our tailored services include route scouting and selection, initial scale-up, and project risk management. To address your late development project needs, we ensure you are successfully supported through process design and assessment, scale-up for commercial manufacture, tech transfer and post-approval improvements. We also possess a range of critical enabling technologies, including catalysis, material science, pre-formulation, high potency API development, and analytical development.
From candidate selection through product launch and beyond, speak to Simon and Joe about how CatSci can de-risk your pharmaceutical pipeline and accelerate your path to clinic. We are your trusted innovation partner for medicines development, and the CatSci team are looking forward to networking with the community and discussing how we can meet your dynamic portfolio demands.
If you want to arrange a meeting with Joe and Simon and DCAT, get in touch here.